You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動丨振東製藥(300158.SZ)大跌近8% 以58億元出售優質資產“朗迪製藥”令市場困惑
格隆匯 08-18 14:52
格隆匯8月18日丨振東製藥(300158.SZ)放量大跌近8%,報7.26元,總市值75億元。振東製藥昨晚公吿,計劃將全資子公司朗迪製藥出售給上海方朗企業管理有限責任公司,朗迪製藥正是知名鈣片品牌朗迪鈣的產銷商,交易作價總計為58億元,全部以現金形式支付對價。朗迪製藥近年來發展迅速,通過公吿的財務數據顯示,2020年營收13.27億元,淨利潤3.57億元。2021年前四個月營收2.6億元,淨利潤9,565.32萬元。振東製藥今日的股價表現,似乎顯示出市場的困惑和不看好。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account